跳至主要内容
临床试验/NCT06664060
NCT06664060尚未招募早期 1 期

Efficacy of Two Nutritional Supplements on Healing and Bone Density in the Jaws

Universidad de Granada0 个研究点目标入组 60 人开始时间: 2025年1月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
尚未招募
入组人数
60
主要终点
diensional changes

研究概览

简要总结

In view of the above and the possible improvements in terms of postoperative morbidity and tissue repair in oral surgery, this study is justified, the general objective of which would be:

'To evaluate the efficacy of perioperative oral administration of two nutritional supplements based on vitamins and antioxidants (Osteoimplant Complex® and Osteoimplant®), using mandibular third molar surgery as a study model, assessing postoperative symptomatology and bone density'.

The null hypothesis of this study is: 1) the administration of the perioperative nutritional complex (Osteoimplant Complex® and Osteoimplant®) did not improve postoperative symptoms and 2) neither did it increase bone density after lower third molar extraction.

详细描述

In view of the above and the possible improvements in terms of postoperative morbidity and tissue repair in oral surgery, this study is justified, the general objective of which would be:

'To evaluate the efficacy of perioperative oral administration of two nutritional supplements based on vitamins and antioxidants (Osteoimplant Complex® and Osteoimplant®), using mandibular third molar surgery as a study model, assessing postoperative symptomatology and bone density'.

The null hypothesis of this study is: 1) the administration of the perioperative nutritional complex (Osteoimplant Complex® and Osteoimplant®) did not improve postoperative symptoms and 2) neither did it increase bone density after lower third molar extraction.

Study design. It is a randomised clinical trial (RCT), double blind controlled (neither the patient nor the examiner collecting the data knows the allocation group) and split-mouth to evaluate the efficacy of the perioperative oral administration of two nutritional complexes on postoperative symptoms, wound healing and bone density 8 weeks after the extraction of a mandibular third molar.

Composition of the nutritional supplements. A. Preoperative nutritional supplement, Osteoimplant Complex®: Ovocet®, vitamin C 48.5mg, coenzyme Q10 41.3mg, zinc 35mg, beta carotene 10% 25mg, bioflavonoids citrus 60% 20.83mg, vitamin E, magnesium 15mg.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients presenting both lower third molars.
  • Adult patients between 18 and 40 years of age.
  • Anaesthetic risk ASA I-II (American Society of Anaesthesiologists classification) [14].
  • Absence of drug or food allergies that could compromise our study (e.g. egg).
  • Signed informed consent.

排除标准

  • Age not between 18-40 years.
  • Pregnant or breastfeeding women.
  • Presenting decompensated metabolic disease.
  • Poor periodontal status (≥10% plaque index and bleeding index).
  • Patients who have undergone radiotherapy in the last five years.
  • Patients who will not comply with the study guidelines.
  • Unsigned informed consent.
  • History of allergy to any study medication or related drugs (e.g. egg).
  • Patients with a history of renal colic.

研究组 & 干预措施

placebo

Placebo Comparator

干预措施: Placebo (Drug)

osteoimplant

Experimental

干预措施: osteoimplant (Drug)

结局指标

主要结局

diensional changes

时间窗: From the extraction (T0) to 8 weeks after (T1) extraction

Dimensional changes shall be assessed by a surgeon previously instructed by a specialised radiologist, by means of CBCT scans performed before (T0) and 8 weeks after (T1) extraction to obtain thus: Dimensional changes, evaluating the horizontal and vertical dimensions of hard tissue taking as a reference the amelocentric limit (LAC) of the adjacent tooth, so as to assess whether there has been loss of hard tissue following extraction and healing. For this purpose, three sections (A, B and C) shall be made at 5, 7 and 9 mm, taking as point 0 the imaginary horizontal line marked by the LAC of the adjacent tooth.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Francisco Javier Manzano-Moreno

PhD, DDS

Universidad de Granada

相似试验